Discussion on "statistical issues arising in the Women's Health Initiative"

Biometrics

Volumn 61, Issue 4, 2005, Pages 914-918

  DeMets, David L ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WOMEN'S HEALTH INITIATIVE;

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CAROTENE; CLOFIBRATE; ESTROGEN; GESTAGEN; HORMONE DERIVATIVE; SIMVASTATIN; STATIN;

BLOOD CLOTTING DISORDER; CANCER RISK; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIETARY INTAKE; HORMONAL THERAPY; HUMAN; LUNG CANCER; LUNG EMBOLISM; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; NOTE; STROKE; TREATMENT OUTCOME;

EID: 33745224353     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.0006-341X.2005.454_4.x     Document Type: Note

References (12)

1. Albert, J. M. and DeMets, D. L. ( 1994). On a model-based approach to estimating efficacy in clinical trials. Statistics in Medicine 13, 2323 2335.
2. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group 1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine 330, 1029 1035.
3. Canner, P. L. ( 1991). Covariate adjustment of treatment effects in clinical trials. Controlled Clinical Trials 12, 359 366.
4. Coronary Drug Project Research Group 1975). Clofibrate and niacin in coronary heart disease. Journal of the American Medical Association 231, 360 381.
5. Dawber, T. R., Meadors, G. F., and Moore, F. E. J. ( 1951). Epidemiological approaches to heart disease: The Framingham Study. American Journal of Public Health 41, 279 286.
6. Freedman, L., Anderson, G., Kipnis, V., Prentice, R., Wang, C. Y., Rossouw, J., Wittes, J., and DeMets, D. L. ( 1996). Approaches to monitoring results of long-term disease prevention trials: Examples from the Women's Health Initiative. Controlled Clinical Trials 17, 509 525.
7. Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., Willett, W., and Peto, R. ( 1996). Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. New England Journal of Medicine 334, 1145 1149.
8. Omenn, G. S., Goodman, G., Thornquist, M., et al 1994). The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Research 54 ( 7 suppl. 2038s 2043s.
9. Scandinavian Simvistatin Survival Study 1994). Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: Scandinavian Simvistatin Survival Study (4S). Lancet 344, 1383 1389.
10. Women's Health Initiative Steering Committee 2004). Effect of conjugated equine estrogen in post menopausal women with hysterectomy: The Women's Health Initiative randomized clinical trial. Journal of the American Medical Association 291, 1701 1712.
11. Women's Health Initiative Study Group 1998). Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials 19, 61 109.
12. Writing Group for the Women's Health Initiative Investigators 1998). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288, 321 333.